What are the major opportunities in the Emerging Infectious Disease Diagnostics market? What are the strategies for the Emerging Infectious Disease Diagnostics market?

For detailed insights on the major opportunities and strategies in the Emerging Infectious Disease Diagnostics market, Read More

How does the Emerging Infectious Disease Diagnostics market relate to the overall economy and other similar markets?

For detailed insights on Emerging Infectious Disease Diagnostics's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Emerging Infectious Disease Diagnostics market growth? SWOT analysis of the Emerging Infectious Disease Diagnostics market.

For detailed insights on the key dynamics influencing the Emerging Infectious Disease Diagnostics market growth and SWOT analysis of the Emerging Infectious Disease Diagnostics industry, Read More

Emerging Infectious Disease Diagnostics Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Emerging Infectious Disease Diagnostics Market Report 2026

Name: Emerging Infectious Disease Diagnostics Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Infection Type (Viral, Bacterial, Fungal, Other Infections), By Disease Type (Respiratory Infections, Gastrointestinal Infections, Sexually Transmitted Infections (STIs), Other Disease Types), By Technology (Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), Next-Generation Sequencing (NGS), Immunodiagnostics, Other Technologies), By Application (Laboratory Testing, Point-of-Care Testing), By End-User (Hospitals And Clinics, Diagnostics Laboratories, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Emerging Infectious Disease Diagnostics Market Overview

• Emerging Infectious Disease Diagnostics market size has reached to $24.34 billion in 2025

• Expected to grow to $38.54 billion in 2030 at a compound annual growth rate (CAGR) of 9.6%

• Growth Driver: Impact Of Rising Zoonotic Diseases On Emerging Infectious Disease Diagnostics Market

• Market Trend: Advancing High-Throughput Multiplex Diagnostic Innovation For Emerging Diseases

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Emerging Infectious Disease Diagnostics Market?

Emerging infectious disease diagnostics refers to the advanced methods and tools used to detect new or re-emerging infectious diseases caused by pathogens such as viruses, bacteria, or parasites. These diagnostics leverage cutting-edge technologies such as molecular testing, genomics, and rapid assays to identify infections quickly and accurately, improving public health responses. They are crucial in monitoring and controlling outbreaks, as well as in developing targeted treatments and vaccines.

The main infection types of emerging infectious disease diagnostics are viral, bacterial, fungal, and others. Viral infections are diseases caused by viruses, which are tiny pathogens that replicate inside the host's cells. The disease includes respiratory infections, gastrointestinal infections, and sexually transmitted infections (STIs), and the technologies are polymerase chain reaction (PCR), isothermal nucleic acid amplification technology (INAAT), next-generation sequencing (NGS), immunodiagnostics, and others. The different applications are laboratory testing and point-of-care testing and are used by various end-users such as hospitals and clinics, diagnostics laboratories, and others.

Emerging Infectious Disease Diagnostics Market Global Report 2026 Market Report bar graph

What Is The Emerging Infectious Disease Diagnostics Market Size and Share 2026?

The emerging infectious disease diagnostics market size has grown strongly in recent years. It will grow from $24.34 billion in 2025 to $26.75 billion in 2026 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to increasing frequency of infectious disease outbreaks, expansion of public health surveillance programs, rising investments in laboratory infrastructure, growing demand for rapid diagnostic solutions, advancements in molecular testing technologies.

What Is The Emerging Infectious Disease Diagnostics Market Growth Forecast?

The emerging infectious disease diagnostics market size is expected to see strong growth in the next few years. It will grow to $38.54 billion in 2030 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to increasing focus on pandemic preparedness, rising adoption of next-generation sequencing diagnostics, expansion of decentralized testing models, growing integration of ai-driven diagnostic analytics, increasing government funding for disease monitoring. Major trends in the forecast period include increasing deployment of rapid molecular diagnostic platforms, rising adoption of point-of-care testing solutions, growing integration of genomic surveillance tools, expansion of multiplex diagnostic assays, enhanced focus on early outbreak detection.

Book your 30 minutes free consultation with our research experts

Global Emerging Infectious Disease Diagnostics Market Segmentation

1) By Infection Type: Viral, Bacterial, Fungal, Other Infections

2) By Disease Type: Respiratory Infections, Gastrointestinal Infections, Sexually Transmitted Infections (STIs), Other Disease Types

3) By Technology: Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), Next-Generation Sequencing (NGS), Immunodiagnostics, Other Technologies

4) By Application: Laboratory Testing, Point-of-Care Testing

5) By End-User: Hospitals And Clinics, Diagnostics Laboratories, Other End-Users

Subsegments:

1) By Viral: Respiratory Viruses, Hepatitis Viruses, HIV and Retroviruses, Arboviruses, Herpesviruses, Gastrointestinal Viruses, Emerging Viral Infections

2) By Bacterial: Tuberculosis (TB), Methicillin-Resistant Staphylococcus Aureus (MRSA), Escherichia Coli (E. coli) Infections, Streptococcus and Pneumococcus Infections, Clostridium Infections, Neisseria, Emerging Drug-Resistant Bacteria

3) By Fungal: Candidiasis, Aspergillosis, Cryptococcosis, Histoplasmosis, Coccidioidomycosis, Pneumocystis Pneumonia (PCP), Emerging Fungal Infections

4) By Other Infections: Parasitic Infections, Protozoan Infections, Prion Diseases, Helminthic Infections, Non-Pathogenic or Environmental Infections

What Is The Driver Of The Emerging Infectious Disease Diagnostics Market?

The rising incidence of zoonotic diseases is expected to propel the growth of the emerging infectious disease diagnostics market going forward. Zoonotic diseases refer to infections that can be transmitted from animals to humans, caused by bacteria, viruses, parasites, or fungi. The rising incidence of zoonotic diseases is primarily due to increased human-wildlife interactions, habitat destruction, and global travel, which facilitate pathogen transmission across species. Emerging infectious disease diagnostics help manage zoonotic diseases by enabling early detection and accurate identification of pathogens, allowing for prompt intervention, effective treatment, and better containment of disease outbreaks, thereby reducing transmission from animals to humans. For instance, in June 2025, according to the Centers for Disease Control and Prevention, a US-based government public-health agency, 48 states and the District of Columbia reported 2,770 human arboviral disease cases in 2023, up from 1,247 cases in 2022, including 2,022 hospitalizations (73%) and 208 deaths (8%), with West Nile virus being the most commonly reported domestic arboviral disease in 2023, accounting for 2,628 cases (95%). Therefore, the rising incidence of zoonotic diseases is driving the emerging infectious disease diagnostics industry.

Key Players In The Global Emerging Infectious Disease Diagnostics Market

Major companies operating in the emerging infectious disease diagnostics market are Roche Diagnostics, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers, Becton Dickinson and Company, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Hologic Inc., Illumina Inc., bioMérieux SA, QuidelOrtho Corporation, Bio-Rad Laboratories, Inc., Qiagen N.V., DiaSorin S.p.A., Randox Laboratories Ltd., Meridian Bioscience Inc., Sekisui Diagnostics LLC, Copan Diagnostics, Co-Diagnostics Inc., T2 Biosystems Inc.

Global Emerging Infectious Disease Diagnostics Market Trends and Insights

Major companies operating in the emerging infectious disease diagnostics market are focusing on developing innovative solutions, such as temperature-activated generation of signal (TAGS) technology, to enhance rapid detection, high-throughput screening, and improved outbreak response capabilities. TAGS technology is an advanced multiplex PCR method that uses controlled temperature activation to generate optical signals for simultaneous identification of multiple pathogens from a single sample, enabling capabilities such as broad syndromic testing, faster turnaround times, and optimized laboratory workflows. For instance, in September 2024, F. Hoffmann-La Roche AG, a Switzerland-based diagnostics and biotechnology company, launched the cobas Respiratory flex test, a TAGS-powered molecular diagnostic designed to detect up to 12 common respiratory viruses from one patient sample, featuring automated high-throughput analysis, flexible pathogen panel configuration, and compatibility with cobas 5800, 6800, and 8800 systems. cobas Respiratory flex improves timely detection of infectious agents, strengthens clinical decision-making, and supports better preparedness for emerging disease threats

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Emerging Infectious Disease Diagnostics Market?

In May 2024, Bruker Corporation, a US-based provider of scientific instruments and diagnostic solutions, acquired ELITechGroup for $942 million (€870 millions). With this acquisition, Bruker gains access to ELITech’s sample to answer molecular diagnostics platforms such as InGenius and BeGenius and a broad infectious disease assay portfolio, thereby enhancing Bruker’s molecular diagnostics and in vitro diagnostics capabilities and expanding its reach in hospital and clinical laboratory infectious disease testing globally. ELITechGroup is a France-based in vitro diagnostics company specializing in molecular diagnostics, biomedical systems, and microbiology.

Regional Outlook

North America was the largest region in the emerging infectious disease diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Emerging Infectious Disease Diagnostics Market?

The emerging infectious disease diagnostics market consists of revenues earned by entities by providing services such as laboratory testing, diagnostic tool development, clinical interpretation of test results, surveillance and reporting, and the provision of telehealth consultations. The market value includes the value of related goods sold by the service provider or included within the service offering. The emerging infectious disease diagnostic market also includes sales of rapid test kits, polymerase chain reaction (PCR) machines, molecular diagnostic assays, sequencing platforms, point-of-care diagnostic devices, and biosensors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Emerging Infectious Disease Diagnostics Market Report 2026?

The emerging infectious disease diagnostics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the emerging infectious disease diagnostics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Emerging Infectious Disease Diagnostics Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$26.75 billion
Revenue Forecast In 2035	$38.54 billion
Growth Rate	CAGR of 9.9% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Infection Type, Disease Type, Technology, Application, End-User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Roche Diagnostics, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers, Becton Dickinson and Company, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Hologic Inc., Illumina Inc., bioMérieux SA, QuidelOrtho Corporation, Bio-Rad Laboratories, Inc., Qiagen N.V., DiaSorin S.p.A., Randox Laboratories Ltd., Meridian Bioscience Inc., Sekisui Diagnostics LLC, Copan Diagnostics, Co-Diagnostics Inc., T2 Biosystems Inc.
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Emerging Infectious Disease Diagnostics Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Emerging Infectious Disease Diagnostics Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Emerging Infectious Disease Diagnostics Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Emerging Infectious Disease Diagnostics Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.1.5 Industry 4.0 & Intelligent Manufacturing

4.2. Major Trends

4.2.1 Increasing Deployment Of Rapid Molecular Diagnostic Platforms

4.2.2 Rising Adoption Of Point-Of-Care Testing Solutions

4.2.3 Growing Integration Of Genomic Surveillance Tools

4.2.4 Expansion Of Multiplex Diagnostic Assays

4.2.5 Enhanced Focus On Early Outbreak Detection

5. Emerging Infectious Disease Diagnostics Market Analysis Of End Use Industries

5.1 Hospitals And Clinics

5.2 Diagnostic Laboratories

5.3 Public Health Agencies

5.4 Research Institutes

5.5 Biotechnology Companies

6. Emerging Infectious Disease Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Emerging Infectious Disease Diagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Emerging Infectious Disease Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Emerging Infectious Disease Diagnostics Market Size, Comparisons And Growth Rate Analysis

7.3. Global Emerging Infectious Disease Diagnostics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Emerging Infectious Disease Diagnostics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Emerging Infectious Disease Diagnostics Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Emerging Infectious Disease Diagnostics Market Segmentation

9.1. Global Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Viral, Bacterial, Fungal, Other Infections

9.2. Global Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Respiratory Infections, Gastrointestinal Infections, Sexually Transmitted Infections (STIs), Other Disease Types

9.3. Global Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), Next-Generation Sequencing (NGS), Immunodiagnostics, Other Technologies

9.4. Global Emerging Infectious Disease Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Laboratory Testing, Point-of-Care Testing

9.5. Global Emerging Infectious Disease Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals And Clinics, Diagnostics Laboratories, Other End-Users

9.6. Global Emerging Infectious Disease Diagnostics Market, Sub-Segmentation Of Viral, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Respiratory Viruses, Hepatitis Viruses, HIV and Retroviruses, Arboviruses, Herpesviruses, Gastrointestinal Viruses, Emerging Viral Infections

9.7. Global Emerging Infectious Disease Diagnostics Market, Sub-Segmentation Of Bacterial, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Tuberculosis (TB), Methicillin-Resistant Staphylococcus Aureus (MRSA), Escherichia Coli (E. coli) Infections, Streptococcus and Pneumococcus Infections, Clostridium Infections, Neisseria, Emerging Drug-Resistant Bacteria

9.8. Global Emerging Infectious Disease Diagnostics Market, Sub-Segmentation Of Fungal, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Candidiasis, Aspergillosis, Cryptococcosis, Histoplasmosis, Coccidioidomycosis, Pneumocystis Pneumonia (PCP), Emerging Fungal Infections

9.9. Global Emerging Infectious Disease Diagnostics Market, Sub-Segmentation Of Other Infections, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Parasitic Infections, Protozoan Infections, Prion Diseases, Helminthic Infections, Non-Pathogenic or Environmental Infections

10. Emerging Infectious Disease Diagnostics Market Regional And Country Analysis

10.1. Global Emerging Infectious Disease Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Emerging Infectious Disease Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Emerging Infectious Disease Diagnostics Market

11.1. Asia-Pacific Emerging Infectious Disease Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Emerging Infectious Disease Diagnostics Market

12.1. China Emerging Infectious Disease Diagnostics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Emerging Infectious Disease Diagnostics Market

13.1. India Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Emerging Infectious Disease Diagnostics Market

14.1. Japan Emerging Infectious Disease Diagnostics Market Overview

14.2. Japan Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Emerging Infectious Disease Diagnostics Market

15.1. Australia Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Emerging Infectious Disease Diagnostics Market

16.1. Indonesia Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Emerging Infectious Disease Diagnostics Market

17.1. South Korea Emerging Infectious Disease Diagnostics Market Overview

17.2. South Korea Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Emerging Infectious Disease Diagnostics Market

18.1. Taiwan Emerging Infectious Disease Diagnostics Market Overview

18.2. Taiwan Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Emerging Infectious Disease Diagnostics Market

19.1. South East Asia Emerging Infectious Disease Diagnostics Market Overview

19.2. South East Asia Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Emerging Infectious Disease Diagnostics Market

20.1. Western Europe Emerging Infectious Disease Diagnostics Market Overview

20.2. Western Europe Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Emerging Infectious Disease Diagnostics Market

21.1. UK Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Emerging Infectious Disease Diagnostics Market

22.1. Germany Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Emerging Infectious Disease Diagnostics Market

23.1. France Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Emerging Infectious Disease Diagnostics Market

24.1. Italy Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Emerging Infectious Disease Diagnostics Market

25.1. Spain Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Emerging Infectious Disease Diagnostics Market

26.1. Eastern Europe Emerging Infectious Disease Diagnostics Market Overview

26.2. Eastern Europe Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Emerging Infectious Disease Diagnostics Market

27.1. Russia Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Emerging Infectious Disease Diagnostics Market

28.1. North America Emerging Infectious Disease Diagnostics Market Overview

28.2. North America Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Emerging Infectious Disease Diagnostics Market

29.1. USA Emerging Infectious Disease Diagnostics Market Overview

29.2. USA Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Emerging Infectious Disease Diagnostics Market

30.1. Canada Emerging Infectious Disease Diagnostics Market Overview

30.2. Canada Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Emerging Infectious Disease Diagnostics Market

31.1. South America Emerging Infectious Disease Diagnostics Market Overview

31.2. South America Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Emerging Infectious Disease Diagnostics Market

32.1. Brazil Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Emerging Infectious Disease Diagnostics Market

33.1. Middle East Emerging Infectious Disease Diagnostics Market Overview

33.2. Middle East Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Emerging Infectious Disease Diagnostics Market

34.1. Africa Emerging Infectious Disease Diagnostics Market Overview

34.2. Africa Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Segmentation By Disease Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Emerging Infectious Disease Diagnostics Market Regulatory and Investment Landscape

36. Emerging Infectious Disease Diagnostics Market Competitive Landscape And Company Profiles

36.1. Emerging Infectious Disease Diagnostics Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Emerging Infectious Disease Diagnostics Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Emerging Infectious Disease Diagnostics Market Company Profiles

36.3.1. Roche Diagnostics Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis

37. Emerging Infectious Disease Diagnostics Market Other Major And Innovative Companies

Becton Dickinson and Company, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Hologic Inc., Illumina Inc., bioMérieux SA, QuidelOrtho Corporation, Bio-Rad Laboratories, Inc., Qiagen N.V., DiaSorin S.p.A., Randox Laboratories Ltd., Meridian Bioscience Inc., Sekisui Diagnostics LLC, Copan Diagnostics

38. Global Emerging Infectious Disease Diagnostics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Emerging Infectious Disease Diagnostics Market

40. Emerging Infectious Disease Diagnostics Market High Potential Countries, Segments and Strategies

40.1 Emerging Infectious Disease Diagnostics Market In 2030 - Countries Offering Most New Opportunities

40.2 Emerging Infectious Disease Diagnostics Market In 2030 - Segments Offering Most New Opportunities

40.3 Emerging Infectious Disease Diagnostics Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Emerging Infectious Disease Diagnostics Market, Overview Of Key Products - Product Examples

Table 2: Global Emerging Infectious Disease Diagnostics Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Emerging Infectious Disease Diagnostics Market, Supply Chain Analysis

Table 4: Global Emerging Infectious Disease Diagnostics Market, Major Raw Material Providers

Table 5: Global Emerging Infectious Disease Diagnostics Market, Major Resource Providers

Table 6: Global Emerging Infectious Disease Diagnostics Market, Major Manufacturers (Suppliers)

Table 7: Global Emerging Infectious Disease Diagnostics Market, Major Distributors And Channel Partners

Table 8: Global Emerging Infectious Disease Diagnostics Market, Key Technologies & Future Trends

Table 9: Global Emerging Infectious Disease Diagnostics Market, Major Trends

Table 10: Global Emerging Infectious Disease Diagnostics Market, Major End Users

Table 11: Global Emerging Infectious Disease Diagnostics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Emerging Infectious Disease Diagnostics Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Emerging Infectious Disease Diagnostics Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Emerging Infectious Disease Diagnostics Market - TAM, US$ Billion, 2025

Table 15: Global Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Emerging Infectious Disease Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Emerging Infectious Disease Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Emerging Infectious Disease Diagnostics Market, Sub-Segmentation Of Viral, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Emerging Infectious Disease Diagnostics Market, Sub-Segmentation Of Bacterial, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Emerging Infectious Disease Diagnostics Market, Sub-Segmentation Of Fungal, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Emerging Infectious Disease Diagnostics Market, Sub-Segmentation Of Other Infections, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Emerging Infectious Disease Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Global Emerging Infectious Disease Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: Asia-Pacific, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: China, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: India, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Japan, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Australia, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: Indonesia, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: South Korea, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: Taiwan, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: South East Asia, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: Western Europe, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: UK, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Germany, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: France, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Italy, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Spain, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Eastern Europe, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: Russia, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: North America, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: USA, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: Canada, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: South America, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Brazil, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Middle East, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Africa, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 98: Global Emerging Infectious Disease Diagnostics Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 99: Global Emerging Infectious Disease Diagnostics Market - Company Scoring Matrix

Table 100: Roche Diagnostics Financial Performance

Table 101: Thermo Fisher Scientific Inc. Financial Performance

Table 102: Abbott Laboratories Financial Performance

Table 103: Danaher Corporation Financial Performance

Table 104: Siemens Healthineers Financial Performance

Table 105: Global Emerging Infectious Disease Diagnostics Market, Competitive Benchmarking (In USD Billions)

Table 106: Global Emerging Infectious Disease Diagnostics Market, Competitive Dashboard

Table 107: Global Emerging Infectious Disease Diagnostics Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 108: Global, Emerging Infectious Disease Diagnostics Market Size Gain ($ Billion), Segmentation By Infection Type, 2025 – 2030

Table 109: Global, Emerging Infectious Disease Diagnostics Market Size Gain ($ Billion), Segmentation By Disease Type, 2025 – 2030

Table 110: Global, Emerging Infectious Disease Diagnostics Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030

List Of Figures

Figure 1: Global Emerging Infectious Disease Diagnostics Market, Overview Of Key Products - Product Examples

Figure 2: Global Emerging Infectious Disease Diagnostics Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Emerging Infectious Disease Diagnostics Market, Supply Chain Analysis

Figure 4: Global Emerging Infectious Disease Diagnostics Market, Major Raw Material Providers

Figure 5: Global Emerging Infectious Disease Diagnostics Market, Major Resource Providers

Figure 6: Global Emerging Infectious Disease Diagnostics Market, Major Manufacturers (Suppliers)

Figure 7: Global Emerging Infectious Disease Diagnostics Market, Major Distributors And Channel Partners

Figure 8: Global Emerging Infectious Disease Diagnostics Market, Key Technologies & Future Trends

Figure 9: Global Emerging Infectious Disease Diagnostics Market, Major Trends

Figure 10: Global Emerging Infectious Disease Diagnostics Market, Major End Users

Figure 11: Global Emerging Infectious Disease Diagnostics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Emerging Infectious Disease Diagnostics Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Emerging Infectious Disease Diagnostics Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Emerging Infectious Disease Diagnostics Market - TAM, US$ Billion, 2025

Figure 15: Global Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Emerging Infectious Disease Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Emerging Infectious Disease Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Emerging Infectious Disease Diagnostics Market, Sub-Segmentation Of Viral, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Emerging Infectious Disease Diagnostics Market, Sub-Segmentation Of Bacterial, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Emerging Infectious Disease Diagnostics Market, Sub-Segmentation Of Fungal, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Emerging Infectious Disease Diagnostics Market, Sub-Segmentation Of Other Infections, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Emerging Infectious Disease Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Global Emerging Infectious Disease Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: Asia-Pacific, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: China, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: India, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Japan, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Australia, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: Indonesia, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: South Korea, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: Taiwan, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: South East Asia, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: Western Europe, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: UK, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Germany, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: France, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Italy, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Spain, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Eastern Europe, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: Russia, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: North America, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: USA, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: Canada, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: South America, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Brazil, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Middle East, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Emerging Infectious Disease Diagnostics Market, Segmentation By Infection Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Emerging Infectious Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Africa, Emerging Infectious Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 98: Global Emerging Infectious Disease Diagnostics Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 99: Global Emerging Infectious Disease Diagnostics Market - Company Scoring Matrix

Figure 100: Roche Diagnostics Financial Performance

Figure 101: Thermo Fisher Scientific Inc. Financial Performance

Figure 102: Abbott Laboratories Financial Performance

Figure 103: Danaher Corporation Financial Performance

Figure 104: Siemens Healthineers Financial Performance

Figure 105: Global Emerging Infectious Disease Diagnostics Market, Competitive Benchmarking (In USD Billions)

Figure 106: Global Emerging Infectious Disease Diagnostics Market, Competitive Dashboard

Figure 107: Global Emerging Infectious Disease Diagnostics Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 108: Global, Emerging Infectious Disease Diagnostics Market Size Gain ($ Billion), Segmentation By Infection Type, 2025 – 2030

Figure 109: Global, Emerging Infectious Disease Diagnostics Market Size Gain ($ Billion), Segmentation By Disease Type, 2025 – 2030

Figure 110: Global, Emerging Infectious Disease Diagnostics Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Transplant Diagnostics Market Report 2026 - Global Outlook – By Type (Reagent And Consumables, Instrument, Software And Services), By Transplant Type (Solid Organ, Stem Cell), By Organ (Kidney, Liver, Heart, Lung, Pancre...

Blood Transfusion Diagnostics Market Report 2026 - Global Outlook – By Type (Instruments And Kits, Reagents, Other Types), By Technology (Western Blot, ELISA, Nucleic Acid Amplification, Fluorescence Assay, Rapid Test), ...

Cancer Diagnostics Market Report 2026 - Global Outlook – By Products (Companion Diagnostics, Molecular Diagnostics), By Method (Biopsy, Endoscopy, Tumor Biomarker Tests, Imaging), By Application (Cervical Cancer, Breast ...

Molecular Diagnostics Devices And Equipment Market Report 2026 - Global Outlook – By Product (Instruments, Reagents And Consumables, Software), By Technology (DNA(Deoxyribonucleic acid) sequencing, Polymerase chain react...

Breast Cancer Diagnostics Market Report 2026 - Global Outlook – By Type (Imaging, Biopsy, Genomic Tests, Blood Tests, Other Types), By Technology (Fluorescent In Situ Hybridization (FISH), Comparative Genomic Hybridizati...

Cervical Cancer Diagnostics Market Report 2026 - Global Outlook – By Diagnostic Test (Pap Smear Test, HPV Test, Colposcopy, Biopsy and Endocervical Curettage, Other Diagnostic Tests), By Age Group (Below 21, Age between ...

Molecular Diagnostics Global Market Report 2022 – By Technology (Polymerase Chain Reaction (PCR), DNA Sequencing, and Next-Generation Sequencing), By Product (Instruments, Reagents and Consumables, Software and Services)...

Frequently Asked Questions

How big is the Emerging Infectious Disease Diagnostics Market?

The Emerging Infectious Disease Diagnostics market was valued at $24.34 billion in 2025, increased to $26.75 billion in 2026, and is projected to reach $38.54 billion by 2030.

What is the Emerging Infectious Disease Diagnostics market growth?

The global Emerging Infectious Disease Diagnostics market is expected to grow at a CAGR of 9.6% from 2026 to 2035 to reach $38.54 billion by 2035.

Who are the key players in Emerging Infectious Disease Diagnostics market?

Some Key Players in the Emerging Infectious Disease Diagnostics market Include, Roche Diagnostics, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers, Becton Dickinson and Company, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Hologic Inc., Illumina Inc., bioMérieux SA, QuidelOrtho Corporation, Bio-Rad Laboratories, Inc., Qiagen N.V., DiaSorin S.p.A., Randox Laboratories Ltd., Meridian Bioscience Inc., Sekisui Diagnostics LLC, Copan Diagnostics, Co-Diagnostics Inc., T2 Biosystems Inc. .

What is the anticipated growth trend for the Emerging Infectious Disease Diagnostics market?

Major trend in this market includes: Advancing High-Throughput Multiplex Diagnostic Innovation For Emerging Diseases. For further insights on this market. request a sample here

Which region has the most growth potential in the Emerging Infectious Disease Diagnostics market?

North America was the largest region in the emerging infectious disease diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the emerging infectious disease diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.